Real-World Findings Support RASi Continuation in Advanced CKD Real-World Findings Support RASi Continuation in Advanced CKD

Discontinuing renin-angiotensin-system inhibitors in people with type 2 diabetes and chronic kidney disease can lead to a greater risk of adverse outcomes.First Look
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news